MedTrace Logo

Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women

NCT05453357 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-11-12

No results posted yet for this study

Summary

The overall objective is to test the feasibility and acceptability of a remote glucose monitoring program among Marshallese women with PGDM (pre-gestational diabetes mellitus) or GDM (gestational diabetes mellitus) and with limited English proficiency.

Conditions

  • Diabetes, Gestational
  • Diabetes Mellitus Type 2 Pre-Existing

Interventions

DEVICE

iGlucose

The patient will use the monitor as instructed by their healthcare team to monitor their blood glucose.

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Jennifer A Andersen, PhD · University of Arkansas

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2024-10-10
Completion
2024-10-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05453357 on ClinicalTrials.gov